GSK plc (GSK)

Basic

  • Market Cap

    £58.47B

  • EV

    £72.11B

  • Shares Out

    4,076.15M

  • Revenue

    £29.65B

  • Employees

    69,400

Margins

  • Gross

    72.14%

  • EBITDA

    30.98%

  • Operating

    25.83%

  • Pre-Tax

    24.66%

  • Net

    20.48%

  • FCF

    14.2%

Returns (5Yr Avg)

  • ROA

    6.27%

  • ROE

    57.73%

  • ROCE

    15.44%

  • ROIC

    9.76%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    £17.27

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    £7.33

  • Earnings (Dil)

    £1.48

  • FCF

    £1.03

  • Book Value

    £3.24

Growth (CAGR)

  • Rev 3Yr

    -4.7%

  • Rev 5Yr

    -0.41%

  • Rev 10Yr

    1.17%

  • Dil EPS 3Yr

    -2.12%

  • Dil EPS 5Yr

    25.85%

  • Dil EPS 10Yr

    4.32%

  • Rev Fwd 2Yr

    3.07%

  • EBITDA Fwd 2Yr

    0.73%

  • EPS Fwd 2Yr

    5.52%

  • EPS LT Growth Est

    8.4%

Dividends

  • Yield

    —

  • Payout

    37.11%

  • DPS

    £0.56

  • DPS Growth 3Yr

    -17.7%

  • DPS Growth 5Yr

    -11.03%

  • DPS Growth 10Yr

    -5.31%

  • DPS Growth Fwd 2Yr

    0.23%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

30,821.0

33,754.0

24,354.0

24,696.0

29,324.0

29,652.0

Total Revenues % Chg.

2.1%

9.5%

-27.8%

1.4%

18.7%

2.2%

Cost of Goods Sold, Total

9,714.0

10,792.0

7,321.0

8,033.0

9,407.0

8,260.0

Gross Profit

21,107.0

22,962.0

17,033.0

16,663.0

19,917.0

21,392.0

Selling General & Admin Expenses, Total

9,500.0

10,962.0

7,041.0

6,784.0

8,179.0

8,965.0

R&D Expenses

3,799.0

4,405.0

4,397.0

4,627.0

5,153.0

5,671.0

Other Operating Expenses

313.0

-606.0

-455.0

-382.0

-737.0

-903.0

Other Operating Expenses, Total

13,612.0

14,761.0

10,983.0

11,029.0

12,595.0

13,733.0

Operating Income

7,495.0

8,201.0

6,050.0

5,634.0

7,322.0

7,659.0

Interest Expense, Total

-756.0

-877.0

-844.0

-762.0

-819.0

-777.0

Interest And Investment Income

74.0

79.0

26.0

13.0

62.0

98.0

Net Interest Expenses

-682.0

-798.0

-818.0

-749.0

-757.0

-679.0

Income (Loss) On Equity Invest.

31.0

74.0

33.0

33.0

-2.0

-2.0

Currency Exchange Gains (Loss)

—

—

—

—

—

—

Other Non Operating Income (Expenses)

-16.0

-12.0

-24.0

-6.0

-46.0

-46.0

EBT, Excl. Unusual Items

6,828.0

7,465.0

5,241.0

4,912.0

6,517.0

6,932.0

Restructuring Charges

-813.0

-1,110.0

-1,178.0

-424.0

-321.0

-327.0

Gain (Loss) On Sale Of Investments

23.0

-14.0

-242.0

1.0

256.0

257.0

Gain (Loss) On Sale Of Assets

240.0

541.0

2,857.0

552.0

215.0

215.0

Asset Writedown

-116.0

-83.0

-200.0

-347.0

-296.0

-255.0

Legal Settlements

—

—

—

—

922.0

922.0

Other Unusual Items

-1,362.0

-578.0

-1,308.0

-1,095.0

-1,665.0

-433.0

EBT, Incl. Unusual Items

4,800.0

6,221.0

5,170.0

3,599.0

5,628.0

7,311.0

Income Tax Expense

754.0

953.0

67.0

83.0

707.0

776.0

Earnings From Continuing Operations

4,046.0

5,268.0

5,103.0

3,516.0

4,921.0

6,535.0

Earnings Of Discontinued Operations

—

—

876.0

1,069.0

10,495.0

-5.0

Minority Interest

-423.0

-623.0

-230.0

-200.0

-460.0

-457.0

Net Income

3,623.0

4,645.0

5,749.0

4,385.0

14,956.0

6,073.0

Net Income to Common Incl Extra Items

3,623.0

4,645.0

5,749.0

4,385.0

14,956.0

6,073.0

Net Income to Common Excl. Extra Items

3,623.0

4,645.0

4,873.0

3,316.0

4,461.0

6,078.0

Total Shares Outstanding

3,938.3

3,962.6

3,984.8

4,006.9

4,034.3

4,056.0

Weighted Avg. Shares Outstanding

3,931.2

3,957.6

3,981.0

4,003.0

4,026.0

4,045.5

Weighted Avg. Shares Outstanding Dil

3,976.8

4,012.8

4,030.0

4,052.0

4,084.0

4,103.5

EPS

0.9

1.2

1.4

1.1

3.7

1.5

EPS Diluted

0.9

1.2

1.4

1.1

3.7

1.5

EBITDA

9,351.0

10,321.0

8,100.0

7,756.0

9,469.0

9,186.0